244 results on '"Kesch, C."'
Search Results
2. Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
3. FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies
4. Transkriptomische Analyse von molekularen Faktoren zur Vorhersage des Therapieoutcomes nach 177Lu-PSMA-Radioligandentherapie
5. MRI-guided active surveillance in patients with ISUP 1 prostate cancer - a multi-institutional validation of the discrimination of the PRECISE score
6. The impact of multiple lesions in prostate MRI – insights from the YAU prostate cancer group
7. The highest grade group does not drive the risk of advanced stage when systematic and multiparametric Magnetic Resonance Imaging (MRI)-targeted biopsies are discordant: Results from a large multi-institutional series
8. Robotic partial nephrectomy in patients with a solitary kidney – a multicenter analysis
9. Urinary fistulae after robotic partial nephrectomy – analysis of a multicenter database
10. The more you see the more you miss. PSMA PET/CT is still affected by a substantial risk of underestimation in prostate cancer patients undergoing radical prostatectomy
11. The impact of double-J ureteral stenting before radical cystectomy on the development of upper tract urothelial carcinoma
12. MRI-guided active surveillance in patients with ISUP 1 prostate cancer – A multi-institutional validation of the discrimination of the PRECISE Score
13. Oncological outcomes of pN1 prostate cancer patients treated with radical prostatectomy: Does molecular imaging have a prognostic impact? Results of a large, multi-institutional series
14. Can we rely on available models predicting pathological outcomes in prostate cancer patients staged with 68-Ga PSMA-PET/CT? External validation of the existing nomograms for extracapsular extension and seminal vesicle invasion at radical prostatectomy and development of a novel tool including intraprostatic SUVmax
15. Why do surgeons need to change their intraoperative plan? A multicentric analysis of conversions in 2459 robot-assisted partial nephrectomies
16. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
17. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
18. Head-to-Head Comparison of the Accuracy of Ga-68-FAPI and F-18-FDG PET in the Diagnosis of Tumors
19. Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer
20. Ein neuer Androgenrezeptorantagonist: Darolutamid für Patienten mit nicht fernmetastasiertem, kastrationsresistentem Prostatakarzinom
21. Wertigkeit der multiparametrischen MRT und der MRT-TRUS-Fusionsbiopsie bei primär negativ biopsierten Patienten
22. Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of MRI-targeted biopsy: A study that challenges the dogma
23. Stellenwert der MRT/TRUS-Fusionsbiopsie im Rahmen der Primärbiopsie beim Prostatakarzinom
24. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance
25. 1609P PSMA-PET and PROMISE re-define stage and risk in patients with prostate cancer
26. Assessment of health-related quality of life in patients with advanced prostate cancer current state and future perspectives
27. Taux d'hospitalisations et de complications liés à la RTUTV : analyse du registre français PMSI sur 4 années.
28. FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
29. Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
30. RISK OF ADVERSE RADICAL PROSTATECTOMY OUTCOMES IN PATIENTS DIAGNOSED WITH IUSP <= 2 PROSTATE CANCER ON MRI/TRUS FUSION BIOPSY
31. Challenging the dogma : Should unilateral pelvic lymph node dissection be envisioned in the multiparametric prostate MRI era?
32. Intraoperative microPET/CT imaging for PSMA-positive cancer foci in radical prostatectomy – feasibility study
33. Challenging the dogma: Should unilateral pelvic lymph node dissection be envisioned in the multiparametric prostate MRI era?
34. Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives
35. A1046 - Robotic partial nephrectomy in patients with a solitary kidney – a multicenter analysis
36. A0826 - MRI-guided active surveillance in patients with ISUP 1 prostate cancer – A multi-institutional validation of the discrimination of the PRECISE Score
37. A0626 - Urinary fistulae after robotic partial nephrectomy – analysis of a multicenter database
38. A0433 - Oncological outcomes of pN1 prostate cancer patients treated with radical prostatectomy: Does molecular imaging have a prognostic impact? Results of a large, multi-institutional series
39. A0434 - The more you see the more you miss. PSMA PET/CT is still affected by a substantial risk of underestimation in prostate cancer patients undergoing radical prostatectomy
40. A0313 - The impact of multiple lesions in prostate MRI – insights from the YAU prostate cancer group
41. A0291 - The highest grade group does not drive the risk of advanced stage when systematic and multiparametric Magnetic Resonance Imaging (MRI)-targeted biopsies are discordant: Results from a large multi-institutional series
42. P338 - Can we rely on available models predicting pathological outcomes in prostate cancer patients staged with 68-Ga PSMA-PET/CT? External validation of the existing nomograms for extracapsular extension and seminal vesicle invasion at radical prostatectomy and development of a novel tool including intraprostatic SUVmax
43. P273 - The impact of double-J ureteral stenting before radical cystectomy on the development of upper tract urothelial carcinoma
44. Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
45. Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen
46. Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
47. Radical Prostatectomy: Sequelae in the Course of Time
48. Focal Therapy for Prostate Cancer: Complications and Their Treatment
49. FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies
50. Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU prostate cancer working group multi-institutional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.